API TEST Children Are Our Commitment Learn more about a clinical trial evaluating investigational cannabidiol (CBD) gel to see if it helps behavioral issues related to Fragile X syndrome. Qualified participants are: Between 3 and 17 years of age Diagnosed via genetic testing, with Fragile X syndrome In generally good health Apply to Participate Notice: JavaScript is required for this content.